bufalin has been researched along with Cancer of Prostate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, AN; Hu, HY; Qian, BZ; Shen, Z; Wang, YG; Yao, Y; Zhang, JJ; Zhou, XH; Zhou, Y | 1 |
| Chen, Z; Fang, FF; Guo, YY; Liu, Q; Meng, YB; Zhai, XF | 1 |
| Esmann, M; Jiang, RW; Jiang, ST; Jin, L; Li, J; Liu, KW; Luo, C; Middleton, DA; Tian, HY; Ye, WC; Yuan, XF | 1 |
| Jea Chien, E; Kan, SF; Pu, HF; Wang, PS; Yu, CH | 1 |
| Huang, WJ; Kan, SF; Wang, PS; Yeh, JY | 1 |
5 other study(ies) available for bufalin and Cancer of Prostate
| Article | Year |
|---|---|
Bufalin suppresses the migration and invasion of prostate cancer cells through HOTAIR, the sponge of miR-520b.
Topics: Antineoplastic Agents; Bufanolides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; Prostatic Neoplasms; Receptor, Fibroblast Growth Factor, Type 1; RNA, Long Noncoding; Up-Regulation | 2019 |
MiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Bufanolides; Caspase 3; Cell Line, Tumor; Flow Cytometry; Gene Expression; Humans; Male; MicroRNAs; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2 | 2013 |
Synthesis of bufalin derivatives with inhibitory activity against prostate cancer cells.
Topics: Antineoplastic Agents; Bufanolides; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Male; Nuclear Magnetic Resonance, Biomolecular; Prostatic Neoplasms; Sodium-Potassium-Exchanging ATPase | 2014 |
Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells.
Topics: Androgens; Apoptosis; bcl-2-Associated X Protein; Bufanolides; Cell Proliferation; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; fas Receptor; Fluorescent Antibody Technique, Indirect; Formazans; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms; RNA, Messenger; Signal Transduction; Tetrazolium Salts; Tumor Suppressor Protein p53 | 2008 |
Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Bufanolides; Calcium; Cell Division; Dose-Response Relationship, Drug; Humans; Intracellular Fluid; Male; Materia Medica; Prostatic Neoplasms; Sodium-Potassium-Exchanging ATPase; Tumor Cells, Cultured | 2003 |